Biogen | 270.7100 / +2.71% |
Date/Time | 03/05 / 22:00 |
Chg. / Chg.(%) | 7.1400 / +2.71% |
Bid | 260.1200 / 7200 |
Ask | 275.0000 / 6600 |
Open | 265.8300 |
Previous Close | 263.5700 |
High | 273.3300 |
Low | 262.4450 |
Volume [USD] | 157,769,491.7866 |
Volume [Units] | 1,062,495 |
Price fixings | 4147 |
ISIN | US09062X1037 |
Security | BIIB |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 226.750 | ![]() |
|
NASDAQ | 270.7100 | ![]() |
1,062,495 |
IEX | 270.86 | ![]() |
71,007 |
Cboe US | 270.75 | ![]() |
45,588 |
TradeGate | 227.300 | ![]() |
1,906 |
Xetra | 221.25 | ![]() |
1,486 |
Moscow | 20,276.00 | ![]() |
556 |
Vienna Globa.. | 221.85 | ![]() |
384 |
Frankfurt | 220.9000 | ![]() |
285 |
London Inter.. | 270.00 | ![]() |
116 |
gettex | 227.450 | ![]() |
26 |
Stuttgart | 221.250 | ![]() |
16 |
Hannover | 220.10 | ![]() |
8 |
München | 219.05 | ![]() |
0 |
Hamburg | 219.35 | ![]() |
0 |
Düsseldorf | 227.75 | ![]() |
0 |
Berlin | 227.80 | ![]() |
0 |
Mexico | 5,571.19 | ![]() |
73 |
News
- Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
03/04/2021 / 14:00 - GlobeNewswire - Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina
03/04/2021 / 13:47 - GlobeNewswire - Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer
03/04/2021 / 13:25 - GlobeNewswire - Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
03/03/2021 / 13:00 - GlobeNewswire - Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
03/01/2021 / 22:00 - GlobeNewswire